Sinovac Biotech Ltd (SVA): Operating Cash Flow
-$512.18M
Year ended 2025-12-31
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$512.18M | n/m | 2026-06-05, From 2025-01-01 |
| 2024-12-31 | -$56.89M | n/m | 2026-06-05, From 2024-01-01 |
| 2023-12-31 | $138.65M | n/m | 2026-06-05, From 2023-01-01 |
| 2022-12-31 | -$798.12M | n/m | 2026-04-30, From 2022-01-01 |
| 2021-12-31 | $15.32B | n/m | 2026-04-30, From 2021-01-01 |
| 2020-12-31 | $479.31M | n/m | 2023-05-01, From 2020-01-01 |
| 2019-12-31 | $39.07M | +391.9% | 2022-04-29, From 2019-01-01 |
| 2018-12-31 | $7.94M | -86.7% | 2021-04-22, From 2018-01-01 |
| 2017-12-31 | $59.76M | n/m | 2020-04-30, From 2017-01-01 |
| 2016-12-31 | -$13.90M | n/c | 2019-04-29, From 2016-01-01 |
| 2015-12-31 | $4.21M | n/m | 2018-05-11, From 2015-01-01 |
| 2014-12-31 | -$10.13M | n/c | 2017-11-22, From 2014-01-01 |
| 2013-12-31 | $5.58M | n/a | 2016-04-25, From 2013-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$512.18M | n/m |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | -$5.62M | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$42.48M | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $196.93M | +4.4% |
| MannKind Corp (MNKD) | 2025-12-31 | $18.25M | -57.1% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$150.79M | n/m |
| CorMedix Inc. (CRMD) | 2025-12-31 | $175.05M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $35.32M | +39.6% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $37.78M | n/m |
Compare SVA, ARQT, ARDX, INVA side by side · Screen every company in Pharmaceutical Preparations ↗